149. Hemiconvulsion hemiplegia epilepsy syndrome Clinical trials / Disease details
Clinical trials : 25 / Drugs : 35 - (DrugBank : 13) / Drug target genes : 16 - Drug target pathways : 22
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT03857607 (ClinicalTrials.gov) | September 1, 2018 | 26/2/2019 | Natural History Study of ATP1A3-related Disease | Natural History of ATP1A3-related Disease: a Deep Phenotyping-genotyping Project | ATP1A3-related Disease;Alternating Hemiplegia of Childhood;Rapid Onset Dystonia Parkinsonism;CAPOS | Genetic: Whole exome sequencing | Institute of Child Health | Great Ormond Street Hospital for Children NHS Foundation Trust;University College, London | Recruiting | 6 Months | 60 Years | All | 100 | United Kingdom |